Dutronc H, Bocquentin F, Galpérine T, Lafarie-Castet S, Dupon M. [Linezolid, the first oxazolidinone antibiotic].
Med Mal Infect 2005;
35:427-34. [PMID:
16297585 DOI:
10.1016/j.medmal.2005.09.006]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2005] [Accepted: 09/12/2005] [Indexed: 10/25/2022]
Abstract
The spread of multiresistant Staphylococcus and Enterococcus strains required the development of new drugs. Linezolid is the first molecule of a new antibiotic family, oxazolidinones, with an original mechanism of action. In this general review, the authors first present its antibacterial activity, its pharmacokinetic properties, its therapeutic uses in serious Gram-positive infections, pneumonia, skin and soft tissue infections, and also in other indications. They then explain the rules for administration and tolerability.
Collapse